arrow_back Back to App

Research to Improve Detection of Xylazine and Synthetic Opioids in Illicit Drugs.

This law aims to enhance public safety by accelerating research into dangerous psychoactive substances like xylazine and novel synthetic opioids. The National Institute of Standards and Technology (NIST) is tasked with developing faster methods for detecting these substances in illicit drugs. This effort supports a more effective response to the opioid crisis and strengthens public health protection.
Key points
Funding research to develop new, faster technologies for identifying xylazine and other dangerous additives in narcotics.
Establishing cooperation among federal agencies, laboratories, and universities to create standards for safe handling and analysis of these substances.
Mandating a study on the US government's capabilities to respond to threats posed by new psychoactive substances.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_1280
Sponsor: Sen. Cruz, Ted [R-TX]
Process start date: 2023-04-25
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

TRANQ Research Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_1280.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-04-25.

What are the main provisions?

Key points include:

  • Funding research to develop new, faster technologies for identifying xylazine and other dangerous additives in narcotics.
  • Establishing cooperation among federal agencies, laboratories, and universities to create standards for safe handling and analysis of these substances.
  • Mandating a study on the US government's capabilities to respond to threats posed by new psychoactive substances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cruz, Ted [R-TX].

What is the latest detailed status?

The latest detailed status is: Placed on Senate Legislative Calendar under General Orders. Calendar No. 286.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Security